Highly Variable Drug Comparison
Highly Variable Drug Comparison is a reference product comparison method that specifically addresses the bioequivalence assessment of highly variable drugs by employing scaled average bioequivalence or adaptive statistical approaches to account for intra-subject variability exceeding conventional thresholds.
11
Publications
384
Citations
33
Authors
18
Institutions
Publications per year
2017–2026
2
Parents
11
1–5 of 11
33
1
h-index
Korea Research Institute of Bioscience and Biotechnology, South Korea
1 publications · 19 citations
1
h-index
1
h-index
1
h-index
1
h-index
1–5 of 33
18
Daegu Catholic University
Gyeongsan-si, South Korea
1 h-index
1 publications
15 citations
Amgen (United States)
Thousand Oaks, United States
1 h-index
3 publications
36 citations

Peking University
Beijing, China
1 h-index
2 publications
20 citations
Chungnam National University
Daejeon, South Korea
1 h-index
3 publications
45 citations
GlaxoSmithKline (United States)
Philadelphia, United States
1 h-index
4 publications
156 citations

Ewha Womans University
Seoul, South Korea
1 h-index
2 publications
38 citations

University of Toronto
Toronto, Canada
1 h-index
1 publications
12 citations
Gyeongju University
Gyeongju, South Korea
1 h-index
1 publications
19 citations
1–8 of 18
2 publications · 49 citations
2
h-index
Repository · 2 publications · 31 citations
2
h-index
2 publications · 39 citations
2
h-index
1 publications · 12 citations
1
h-index
1 publications · 19 citations
1
h-index
1–5